Featured

Current Issue

Ulutas Genetic Research Journal

Current Issue : 2016, Vol: 1, Issue: 1

ISSN :

Genetic research JournalsISSUES : 4 per year

PUBLISHER : The UMJ Intenational Medical Journal Library

The Ulutas Genetic Research Journal is aimed to serve as scientific research journal related to Genetic Research. The Journal has indexed in Google Scholar, SCOPEMED, CrossRef, Index Copernicus, Index Scholar, Index Journal.

 

Ulutas Gen Res J. Year: 2016, Volume: 1, Issue: 1

Original Research

The Study of Allelic variants of TRAIL-R gene in Multiple Sclerosis patients in Iranian Azari Turkish Patients
Bita Amir Taghavi, Mehrdad Hashemi, Gholamreza Niaei, Seyed Ali Rahmani
Ulutas Gen Res J. 2016; 1(1): 6-10
» Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160101102148

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Restenosis Events After Coronary Stent Placement in Iranian Azari Patients
Naser Aslanabadi, Amir Monfaredan, Gholamreza Niaei, Samad Ghaffari, Bahram Sohrabi, Fatemeh Jahanjoo
Ulutas Gen Res J. 2016; 1(1): 11-17
» Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160210063642

Review Article

MTHFR C677T Polymorphism: Metabolism and Infertility
Papitha P Anand
Ulutas Gen Res J. 2016; 1(1): 1-5
» Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160212020823

Protection of Research Participants

Protection of Research Participants (Statement On Human And Animal Rights)

Adopted from ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html).

When reporting experiments on people, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), or if no formal ethics committee is available, with the Helsinki Declaration as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws. Applicable laws vary from locale to locale, and journals should establish their own policies with legal guidance. Since a journal that archives the consent will be aware of patient identity, some journals may decide that patient confidentiality is better guarded by having the author archive the consent and instead providing the journal with a written statement that attests that they have received and archived written patient consent.

Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, authors should provide assurance, and editors should so note, that such changes do not distort scientific meaning.

The requirement for informed consent should be included in the journal’s instructions for authors. When informed consent has been obtained, it should be indicated in the published article.

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.

Last updated: August 30, 2014 14:54:38

Editorial Policy

Editorial Policy

Ulutas Genetic Research Journal has established a guideline for editorial independence as delineated below. The guideline generally follows that created by the World Association of Medical Editors.
  1. Ulutas Genetic Research Journal is operated by The UMJ Intenational Medical Journal Library, which is publishing organization.
  2. The General Chief Editor (currently, Dr. Recai Ogur) is responsible for independent leadership of Ulutas Genetic Research Journal editorial operations. The General Publishing Editor reports to the Editor-in-Chief (currently Dr. Recai Ogur) for all editorial matters.
  3. Each individual Journal of The UMJ Intenational Medical Journal Library has one or more Editor-in-Chief. These Editors-in-Chief each have their own boards.
  4. The Editor-in-Chief has full authority over the content of Ulutas Genetic Research Journal and its related offerings. This includes summaries and comments on recent medical advances, opinions, blogs and news.
  5. Content-related decisions are based on quality, importance, and value to the users of Ulutas Genetic Research Journal. Contributing authors, editors, Ulutas Genetic Research Journal staff are free to express responsible positions – even if these views are not in agreement with interests, policies or published research, editorial or commentary of The UMJ Intenational Medical Journal Library.
  6. Each The UMJ Intenational Medical Journal Library journal has editorial operations that are completely separate and independent.
  7. Any packaging or combined offering of The UMJ Intenational Medical Journal Library Journals does not affect the independence of editorial decision-making.
  8. Ulutas Genetic Research Journal actively seeks input regarding editorial matters from the physician Editors-in-Chief in an advisory capacity, as well as from the other editorial board members, internal editorial staff, and readers.
  9. Editors-in-Chief of Ulutas Genetic Research Journal is empowered to create content and commentary free of commercial and organizational influence. All authors and editors operate without conflict of interest and all potential conflicts are disclosed (please also see Conflict of Interest Policy).

Publication Ethics and Publication Malpractice Statement

The publication of an article in a peer reviewed journal is an essential model for our journal “Ulutas Genetic Research Journal”.
It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer(s) and the publisher.
Our ethic statements are based on COPE’s Best Practice Guidelines for Journal Editors.

Publication decisions
The editor of the GR is responsible for deciding which of the articles submitted to the journal should be published.
The editor may be guided by the policies of the journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.

Fair play
An editor at any time evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author.

Duties of Reviewers
Contribution to Editorial Decisions
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.

Promptness
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Duties of Authors

Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

Acknowledgement of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.
The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

Editor, Ulutas Genetic Research Journal

Last updated: December 16, 2015 01:13:18

Aims And Scope

The Ulutas Medical Journal (UMJ)

Extensively cover research work with cutting edge forefront innovations and adequate promoting methods. Composing a research paper is an aptitude and have the group of researchers and academicians who are committed to assist study and enhance that aptitude by giving an aide for composing high calibre research papers through associate evaluation. Discriminating assessment of research paper is a prime centre of every part of the UMJ Reviewer Panel for recognizing Plagiarism. We attempt our best to guarantee the variety in every research paper being published in UMJ.

The Ulutas Medical Journal (UMJ) is a 3 monthly, open access, peer-reviewed and fully refereed international journal with very low research paper publication fee. Writing a research paper is a skill and the Ulutas Medical Journal have the team of scientists and academicians who are dedicated to helping learn and improve that skill by providing a guide for writing high-quality research papers through peer review. Critical evaluation of research paper is a prime focus of each member of The Ulutas Medical Journal (UMJ) Reviewer Panel for identifying Plagiarism.

The Editorial Board

current Issues

Scientific Editor-in-Chief

Kemal Türker ULUTAS, MD, HCLD
Antakya Public State Hospitals
Assoc. Administrator of Hospital
Dept. of Clinical Biochemistry
Hatay, TURKEY

Associate Editors

Pinki CHOWDHURY, PhD
Department of Internal Medicine,
Hematology-Oncology University of
Michigan Comprehensive Cancer Center
Ann Arbor, Michigan 48109, USA

Hasan Veysi GUNES, PhD, Professor
Eskižehir Osmangazi University
Dept. of Molecular Cell Biology
Eskisehir, Turkey

Hilal KOCDOR, MD, PhD, Professor
Dokuz Eylul University, Faculty of Medicine
Medical Oncology Institute
Izmir, Turkey

Language Editor

Tuba CULCU, BSc, PhD
Middle East Technical University
Department of Biological Sciences
Ankara, TURKEY

Scientific Advisory Board

Jagadish C DAS, MD, Neonatology, Bangladesh
Pan HF, MD, PhD, Epidemiology and Biostatistic, China
Erdinc NAYIR, MD, Medical Oncology, Turkey
Burkay K. KACIRA, Orthopaedics & Traumatology, Turkey
Nizami DURAN, PhD, Microbiology, Turkey

Guide For Authors

Manuscript submissions

Instructions to authors comply with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” (www.ICMJE.org, updated in April 2010). Editors hold the right to make all the necessary changes to the language and style of the original manuscript in order to adhere to the uniform standards of the Journal.

Article types
Contributions to the Journal are classified into the categories listed in the table below. The maximum word count does NOT include the title, authors and affiliations, abstract, keywords, subheadings, table and figure legends, and references. However, it does include the text in the tables, if any.

 

Category Maximum word count Maximum number of references
Editorial 1500 10
Review 5000 100
Short review 3500 50
Lessons in biostatistics 3000 30
Research integrity corner article 3000 30
Original article 5000 30
Short communication 1500 10
Case report 3000 30

Manuscript preparation

The manuscript should be written in English and uploaded via the online submission system available at ULUTAS Medical Journal Official website.

The following should be submitted:

  1. Cover letter
  2. Title page
  3. Manuscript(without authors and affiliations)
  4. Author statement form
  5. Conflict of interest disclosure form (for each author)
  6. Figure (optional)

Please note that a Manuscript file should not contain any information on the authors and their affiliation. Also, the Manuscript file name should not contain any reference to the author’s name. This is important because all manuscripts are sent for blind peer review. Each corresponding author is required to suggest 3 potential reviewers for the manuscript. Please note that the Editorial board members should not be suggested as reviewers. The author may also suggest opposing reviewers (optional).

 Cover letter

The cover letter should contain the following:

  • corresponding authors’ name
  • short description of the research study (2-3 sentences) and any other information regarding the manuscript that the Editors may find useful;
  • body text word count and number of figures, tables, and graphs in the manuscript;
  • suggested category for the manuscript (e.g., original article, short communication or other);
  • statement on all submissions and previous reports that might be regarded as redundant publications (for example studies based on the same sample, publications of the same biomarker, etc.);
  • reasons why authors presume their work may be of interest to the Journal’s readership.

 Title page

The title page should be a separate page. The title page should include:

  • the full title of the manuscript;
  • short title (up to 50 characters);
  • authors names, affiliations (institution, department, city, country) and e-mail addresses for further correspondence;
  • corresponding author’s e-mail address and full mailing address (institution, department, street, street number, zip code, city, country). Please note that the e-mail address of the corresponding author will be published in the final version of the article if a manuscript is accepted.

The corresponding author should be marked with an asterisk (*). The affiliations should be noted with a superscript number.

For example:

Giuseppe Lippi1*, Emmanuel J Favaloro2 

1Institute of Clinical Chemistry, Department of Morphological and Biomedical Science, University of Verona, Verona, Italy
2Department of Hematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

*Corresponding author: drkemalturker@gmail.com

Manuscript
A manuscript should be prepared as follows:

  • the file should be in MS Word format (*.doc format only, submission system does not support *.docx format);
  • the text should be double-spaced throughout including the title page, abstract, body text, references, acknowledgements, individual tables and legends
  • page format: A4;
  • font: Times New Roman, 12 pt;
  • all margins: 2.5 cm;
  • do NOT use any styles and formatting (no numbering for titles, no bold fonts);
  • do NOT use Headers or Footers; and
  • pages should be numbered throughout.

Please note that the cover letter and title page are not included into the manuscript file. All pages of the manuscript (except for the cover letter and title page, which are attached separately) should be within a single document. Original manuscripts should be structured as follows: Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, Tables and Figures, and References. 

Abstract
All types of manuscripts should contain an abstract. An abstract of 250 words maximum should be provided on a separate page (abstract only, without authors and affiliation). The abstract of an original article should be structured into four headings: IntroductionMaterials and MethodsResults, and Conclusions. For other article types, abstracts do not have to be structured.

Keywords
Please provide 3-5 keywords from MeSH database, when possible, available at http://www.nlm.nih.gov/mesh/meshhome.html 

Introduction
In the Introduction section, the authors should highlight new information in the manuscript, the hypothesis, and the aim of their work. The Introduction section should not contain results and conclusions.

 Materials and Methods
The Materials and Methods section should only include information that was available at the time the study was planned. All information obtained during the study should be provided in the Results section. This section should be structured as follows:

  • Subjects (if research includes human subjects),
  • Materials (otherwise);
  • Methods
  • Statistical analysis

In the Subjects/Materials section it is recommended to include the following:

  • time and place of the study (the dates og the beginning and the end of the study);
  • study design (case-control, cohort, diagnostic accuracy etc.);
  • inclusion and exclusion criteria;
  • relevant demographic and history details (age, gender, diagnostic criteria etc.);

When reporting trials on human subjects, authors should indicate whether the procedures were in accordance with the ethical standards set by the responsible human experimentation committee (institutional and national) and 1975 Helsinki Declaration. All subjects should sign an informed consent form and this information should be expressed in the manuscript. Signed informed consent forms should be archived by the authors. The authors have to provide a written statement that they have received and archived all patient informed consent forms, as required in the Author statement form.

In the Methods section, methods, instruments (give the manufacturer’s name, town and country in parentheses), and procedures should be described in sufficient detail to allow other researchers to reproduce the results. For well-established methods, only references should be provided. In the Statistical analysis section, authors should list all statistical methods used in the study and preselected level of significance (P). If possible, findings should be quantified and presented using appropriate indicators of measurement error or uncertainty (e.g., confidence intervals). For more details, see the article: Simundic AM. Practical recommendations for statistical analysis and data presentation in ULUTAS Medical Journal journal. Biochem Med 2012;22(1):15-23. At the end of this section, authors should specify the statistical software used.

Results
State the main or most important finding first. The data presented in the tables or figures should not be repeated in the text. Graphs should be used as an alternative to tables with many entries; do not present the same data in duplicate (e.g., in both graphs and tables). Exact P-values should be provided for all tested differences (e.g., write P=0.048 instead of P<0.05) rounded to three decimal places.

Discussion
Emphasize the new and important conclusion based on the study results in the context of the best available evidence. Do not repeat the data presented in the Introduction or Results section. Clearly, state the limitations of the study. 

Acknowledgements
All contributors who do not meet the authorship criteria should be listed in the Acknowledgments section. These persons must give verbal permission to be acknowledged. Authors should provide that statement in Author statement form. Financial and material support should also be acknowledged.

References
ULUTAS Medical Journal applies the Vancouver referencing style. Literature citation should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (ICMJE) available at www.ICMJE.org. References should be numbered consecutively, using Arabic numerals in parentheses, in the order of appearance in the text.

For example: Prostatic carcinomas with final score < 7 were considered low-intermediate grade; and, with final score > 7 were considered high-grade (4). References cited only in tables or figures should be numbered in accordance with the sequence established by the first appearance in the text of the table or figure. References should be verified using either an electronic bibliographic source, such as PubMed, or print copies from original sources. Authors are responsible for checking that none of the references refer to retracted articles except in the context of referring to the retraction. Also, the authors should not include DOI numbers at the end of cited reference.

Journal titles should be abbreviated according to the style used in the list of Journals Indexed for MEDLINE, posted by the NLM available at:http://www.nlm.nih.gov/tsd/serials/lji.html. Examples of various reference formats are available at http://www.nlm.nih.gov/bsd/uniform_requirements.html The most common examples are as follows:

 

Journals: Name all authors unless there are more than seven, in which case list the first six-plus et al. For example:

Punglia RS, D’Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level. Cancer 2006;106:1507-13.

 

Chen L, Wang X, Carter SA, Shen YH, Bartsch HR, Thompson RW, et al. A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg 2006;131:1045-52.

 

Book or handbook:
In English: Burtis CA, Ashwood ER, Burns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis, MO: Elsevier Saunders, 2006.

 

Book chapter:
In English: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumours. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

 

Internet source:
Cahill, J., Barkham, M., Hardy, G., Rees, A., Shapiro, D.A., Stiles, W.B. & Macaskill, N. Outcomes of patients completing and not completing cognitive therapy for depression [Electronic version]. British Journal of Clinical Psychology, 2003:42;133-43. Accessed July 19, 2003, fromhttp://www.bps.org.uk/publications/jCP_1.cfm.

Tables
Tables with brief captions should be provided with each on a separate page at the end of the document. Use only horizontal lines of a table grid. Tables should be numbered consecutively using Arabic numerals. Ensure that each table is cited in the text. Each column should have a short heading title and detailed explanation provided in a footnote. All non-standard abbreviations should be explained in table footnotes using the symbols in the following order: *, †, ‡, §, ║, ¶, **, ††, ‡‡, §§, ║║, ¶¶, etc.

Figures
Each figure and its brief caption should be provided on a separate page at the end of the document. Figures should be numbered consecutively according to the order of appearance in the text. Technical editors will redesign or recreate all graphical elements (pictures, schematic presentations etc.) of the manuscript if they do not conform to the uniform style of the Journal.

Units of measurement
Units of measurement should be reported according to the Journal style. For a complete list of acceptable units, please see the abbreviations and measurement units section available at Journal web page under Guidelines to authors section. ULUTAS Medical Journal accepts the International System of Units (SI) except for temperature (degrees Celsius), blood pressure (millimetres of mercury) and enzyme activity (U/L).

Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title of the manuscript. Always spell out abbreviations on the first mention and include the abbreviation in parenthesis unless the abbreviation is a standard unit of measurement. For additional information, see the Abbreviations and measurement units section available at Journal web page under Guidelines to authors section.

Language and style
The manuscript should be written in English in understandable style and checked for correct spelling and use of grammar. The Journal does not provide a language editing service. Authors whose first language is not English are strongly advised to have their manuscript edited by a language professional or fluent English speaker before submission. Please note that this does not guarantee the acceptance of the article for publication. Authors may find the list of several language editing services at Journal webpage in the Guidelines to authors section.ULUTAS Medical Journal does not have any preferences for the use of any particular service provider.

Figures

If for some reason, figures cannot be inserted into the manuscript file, they can be uploaded as separate electronic files. Acceptable image file formats for print publication are: *.jpg, *.bmp or *.tiff; the desired resolution is 150 dpi.

Last updated: March 2015

Archived Issues

Ulutas Gen Res J. Year: 2016, Volume: 1, Issue: 1

Original Research

    1. The Study of Allelic variants of TRAIL-R gene in Multiple Sclerosis patients in Iranian Azari Turkish Patients
      Bita Amir Taghavi, Mehrdad Hashemi, Gholamreza Niaei, Seyed Ali Rahmani
      Ulutas Gen Res J. 2016; 1(1): 6-10
      » Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160101102148

 

    1. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Restenosis Events After Coronary Stent Placement in Iranian Azari Patients
      Naser Aslanabadi, Amir Monfaredan, Gholamreza Niaei, Samad Ghaffari, Bahram Sohrabi, Fatemeh Jahanjoo
      Ulutas Gen Res J. 2016; 1(1): 11-17
      » Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160210063642

 

Review Article

  1. MTHFR C677T Polymorphism: Metabolism and Infertility
    Papitha P Anand
    Ulutas Gen Res J. 2016; 1(1): 1-5
    » Abstract & References » PDF Fulltext» doi: 10.5455/ugrj.20160212020823

 

Editorial and Peer Review Processes

Editorial and Peer Review Processes

Editorial and Peer Review Processes generally follow these steps:

  1. We follow and request from authors, reviewers and editors the “ICJME Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals”.
  2. When an article is submitted to Journal of Intercultural Ethnopharmacology, Editor makes the first check of submitted articles (structure, plagiarism, scientific quality).
  3. The article may be rejected, sent back for structural revision, or sent to at least two reviewers for peer review.
  4. After the peer review process, articles may be rejected, sent back for revision requested by reviewers or accepted for publication.
  5. Revised articles by authors may be accepted, resent to reviewers, resent to authors for additional corrections/revision or rejected.
  6. Authors could not see reviewers’ information. The editor may make authors’ information available to reviewers or not.
  7. Accepted articles are forwarded to the publishing process.
  8. Editor(s) may require additional materials or changes from authors during copy editing, composing, grammatical editing and/or proofreading steps.

Ulutas Genetic Research Journal

Current Issue : 2016, Vol: 1, Issue: 1

ISSN :

ISSUES: 4 per year

PUBLISHER: The UMJ International Medical Journal Library

The Ulutas Genetic Research Journal is aimed to serve as a scientific research journal related to Genetic Research. The Journal has indexed in Google Scholar, SCOPEMED, CrossRef, Index Copernicus, Index Scholar, Index-Journal.